非洲裔美国人阿尔茨海默病新风险位点与通路:荟萃分析
该研究利用阿尔茨海默病遗传学联盟的病例对照与家系数据,在2784例非洲裔美国阿尔茨海默病患者和5222名对照中开展全基因组关联荟萃分析,采用非洲基因组资源面板。结果发现EDEM1、ALCAM、GPC6、VRK3等新位点及IGF1R附近全基因组显著位点,表明白人已知25个位点中仅7个在非洲裔中名义显著,通路总体重叠但具体位点不同。
要点
- 非洲裔美国人中识别出EDEM1、ALCAM、GPC6、VRK3等新风险位点。
- 白人25个已知位点中仅APOE、ABCA7、TREM2、BIN1、CD2AP、FERMT2、WWOX在非洲裔中名义显著。
- 免疫、脂质加工、细胞内转运通路重叠,但具体位点不同。
核心结论
- 非洲裔美国人与非西班牙裔白人阿尔茨海默病主要通路相似,但通路内疾病相关位点不同。
- 分析提示肾脏系统可能为阿尔茨海默病的新机制,尚需进一步探索。
研究设计与样本
- 研究为全基因组关联荟萃分析,使用阿尔茨海默病遗传学联盟的病例对照与家系数据。
- 纳入2784例阿尔茨海默病患者(1944例女性,69.8%)和5222名对照(3743例女性,71.7%),末次评估平均年龄74.2(SD 13.6)岁。
- 招募点分布于美国多地,分析时间为2018年10月至2019年9月,使用非洲基因组资源面板。
主要发现
- 4个新常见位点:EDEM1附近3p26(P = 8.9 × 10-7)、ALCAM附近3q13(P = 9.3 × 10-7)、GPC6内13q31(P = 4.1 × 10-7)、VRK3内19q13.33(P = 3.5 × 10-7)。
- 罕见变异相关位点包括IGF1R附近15q26居间位点达全基因组显著(P = 1.7 × 10-9),另有6个提示显著位点(P ≤ 5 × 10-7),如API5 11p12(P = 8.8 × 10-8)、RBFOX1 16p13(P = 5.4 × 10-7)。
- 脑组织基因表达数据示ALCAM、ARAP1、GPC6、RBFOX1与脑β-淀粉样蛋白负荷相关。
- 非西班牙裔白人25个已知位点中,仅APOE、ABCA7、TREM2、BIN1、CD2AP、FERMT2、WWOX在非洲裔美国人中以名义显著性水平或更强被涉及。
关键数值与推荐
- 全基因组显著阈值以IGF1R附近位点P = 1.7 × 10-9为例,提示显著位点以P ≤ 5 × 10-7列出。
- 4个新常见位点P值范围为3.5 × 10-7至9.3 × 10-7。
- 通路分析支持免疫、脂质加工和细胞内转运通路在非洲裔与白人之间重叠。
临床怎么用
- 提示神经科医生关注非洲裔美国人阿尔茨海默病遗传背景差异,APOE等位点解读需结合人群。
- 免疫、脂质加工、细胞内转运及肾脏系统相关通路可作为风险评估与机制研究的候选方向。
- 遗传发现尚属研究阶段,不直接用于临床基因检测或治疗决策。
局限性
- 原文未报告具体局限性描述。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Compared with non-Hispanic White individuals, African American individuals from the same community are approximately twice as likely to develop Alzheimer disease. Despite this disparity, the largest Alzheimer disease genome-wide association studies to date have been conducted in non-Hispanic White individuals. In the largest association analyses of Alzheimer disease in African American individuals, ABCA7, TREM2, and an intergenic locus at 5q35 were previously implicated. OBJECTIVE: To identify additional risk loci in African American individuals by increasing the sample size and using the African Genome Resource panel. DESIGN, SETTING, AND PARTICIPANTS: This genome-wide association meta-analysis used case-control and family-based data sets from the Alzheimer Disease Genetics Consortium. There were multiple recruitment sites throughout the United States that included individuals with Alzheimer disease and controls of African American ancestry. Analysis began October 2018 and ended September 2019. MAIN OUTCOMES AND MEASURES: Diagnosis of Alzheimer disease. RESULTS: A total of 2784 individuals with Alzheimer disease (1944 female [69.8%]) and 5222 controls (3743 female [71.7%]) were analyzed (mean [SD] age at last evaluation, 74.2 [13.6] years). Associations with 4 novel common loci centered near the intracellular glycoprotein trafficking gene EDEM1 (3p26; P = 8.9 × 10-7), near the immune response gene ALCAM (3q13; P = 9.3 × 10-7), within GPC6 (13q31; P = 4.1 × 10-7), a gene critical for recruitment of glutamatergic receptors to the neuronal membrane, and within VRK3 (19q13.33; P = 3.5 × 10-7), a gene involved in glutamate neurotoxicity, were identified. In addition, several loci associated with rare variants, including a genome-wide significant intergenic locus near IGF1R at 15q26 (P = 1.7 × 10-9) and 6 additional loci with suggestive significance (P ≤ 5 × 10-7) such as API5 at 11p12 (P = 8.8 × 10-8) and RBFOX1 at 16p13 (P = 5.4 × 10-7) were identified. Gene expression data from brain tissue demonstrate association of ALCAM, ARAP1, GPC6, and RBFOX1 with brain β-amyloid load. Of 25 known loci associated with Alzheimer disease in non-Hispanic White individuals, only APOE, ABCA7, TREM2, BIN1, CD2AP, FERMT2, and WWOX were implicated at a nominal significance level or stronger in African American individuals. Pathway analyses strongly support the notion that immunity, lipid processing, and intracellular trafficking pathways underlying Alzheimer disease in African American individuals overlap with those observed in non-Hispanic White individuals. A new pathway emerging from these analyses is the kidney system, suggesting a novel mechanism for Alzheimer disease that needs further exploration. CONCLUSIONS AND RELEVANCE: While the major pathways involved in Alzheimer disease etiology in African American individuals are similar to those in non-Hispanic White individuals, the disease-associated loci within these pathways differ.
引用
- Kunkle BW, Schmidt M, Klein HU, et al. Novel Alzheimer Disease Risk Loci and Pathways in African American Individuals Using the African Genome Resources Panel: A Meta-analysis. JAMA Neurol. 2021. PMID: 33074286. doi:10.1001/jamaneurol.2020.3536
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。